Back to Search
Start Over
Researchers Submit Patent Application, "Enzyme-linked paper-based assay", for Approval (USPTO 20240175868).
- Source :
- Medical Letter on the CDC & FDA; 6/18/2024, p10294-10294, 1p
- Publication Year :
- 2024
-
Abstract
- A patent application has been submitted for a new technology called microfluidic enzyme-linked paper analytical device (mEL-PAD), which aims to improve the performance of lateral flow assays (LFAs) used for point-of-care testing. LFAs are commonly used for rapid diagnostic tests but have limitations in sensitivity and quantification. The mEL-PAD utilizes a vertical flow microfluidic device that incorporates enzyme-linked assays into paper-based devices. This technology has the potential to enhance the analytical performance of LFAs and enable easy-to-use point-of-care tests with high sensitivity and accuracy. The device can be used to detect various analytes, and a smartphone can be used to quantify the color change. [Extracted from the article]
Details
- Language :
- English
- ISSN :
- 15324648
- Database :
- Supplemental Index
- Journal :
- Medical Letter on the CDC & FDA
- Publication Type :
- Periodical
- Accession number :
- 177865446